Tellimer logo
Search icon
Equity Analysis /
United States of America

US : Galmed Pharmaceuticals Ltd. - GLMD | 1Q21 Update: Written Aramchol-meglumine Guidance from FDA Forthcoming

    Contributors
    Ryan Deschner
    Timur Ivannikov
    CGS-CIMB
    13 May 2021
    Published by

    Watchlist

    Tellimer | Start Following

    Start following your markets today

    Follow your key analysts, markets and more so they appear here in your Watchlist - allowing you to keep an eye on the latest updates.